CAR-T therapy modifications provide new promise for cancer immunotherapies
New research led by Dr. John Maher, from the School of Cancer & Pharmaceutical Sciences, working for Leucid Bio and with biotech company LUMICKS, has been published in the February 2022 issue of Frontiers in Immunology.
Mar 8, 2022
0
7